TMSB4X, thymosin beta 4 X-linked, 7114

N. diseases: 130; N. variants: 0
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0006826
Disease: Malignant Neoplasms
Malignant Neoplasms
0.090 Biomarker group BEFREE Thymosinβ-4(Tβ4) is an actin-sequestering protein involved in tumor malignancy. 31048733 2019
CUI: C0006826
Disease: Malignant Neoplasms
Malignant Neoplasms
0.090 AlteredExpression group BEFREE Correction: Hypoxia/reoxygenation-experienced cancer cell migration and metastasis are regulated by Rap1- and Rac1-GTPase activation <i>via</i> the expression of thymosin beta-4. 30680073 2018
CUI: C0006826
Disease: Malignant Neoplasms
Malignant Neoplasms
0.090 AlteredExpression group BEFREE The treatment with N-(β-D-Glucopyranosyl)-N2-acetyl-S-nitroso-D, L-penicillaminamide (SNAP-1), to generate NO, enhanced the transcription of Tβ4 and cancer cell migration. 25271630 2014
CUI: C0006826
Disease: Malignant Neoplasms
Malignant Neoplasms
0.090 AlteredExpression group BEFREE Thymosin beta 4 expression increased with grade of malignancy in gliomas. 24355709 2014
CUI: C0006826
Disease: Malignant Neoplasms
Malignant Neoplasms
0.090 AlteredExpression group BEFREE Expression patterns of Thymosin β4 and cancer stem cell marker CD133 in ovarian cancers. 23055022 2013
CUI: C0006826
Disease: Malignant Neoplasms
Malignant Neoplasms
0.090 Biomarker group BEFREE Thus, Tβ4 provided a potential target of opportunity for cancer management, especially for cancer metastasis therapy. 22856429 2012
CUI: C0006826
Disease: Malignant Neoplasms
Malignant Neoplasms
0.090 Biomarker group BEFREE Thymosin beta-4 (Tβ4), actin-sequestering protein, plays important roles in many cellular functions including cancer cell migrations. 22328534 2012
CUI: C0006826
Disease: Malignant Neoplasms
Malignant Neoplasms
0.090 Biomarker group BEFREE Human thymosin beta 4 (TB4) is a small acidic peptide involved in angiogenesis, wound healing, cancer metastasis and cardiac repair. 17923415 2007
CUI: C0006826
Disease: Malignant Neoplasms
Malignant Neoplasms
0.090 AlteredExpression group BEFREE These findings show that the thymosin beta 4 and beta 10 genes are constitutively expressed at higher levels in embryonic/neoplastic as compared to normal/benign tissues and that thymosin in beta 10 in particular may be a new molecular marker for renal-cell carcinoma as well as other malignancies. 2071228 1991